Conduent Incorporated (Nasdaq: CNDT), a global technology-driven business solutions and services company, today announced the ...

A growing number of GLP-1 users are 'microdosing' - they say small amounts of the drug have helped reduce symptoms of various ...

IF you’ve ever searched for weight loss tips online, you will know the deep rabbit hole that awaits. But now, social media ...

Eli Lilly and Company today announced an agreement with the U.S. government to expand access to its obesity medicines and reduce patient costs. The agreement builds on Lilly's longstanding commitment ...

This month: clinicians’ views on CVD prevention, a possible sleep apnea paradox, microplastics in femoral plaque, and more.

The rise of a grey market in India, where unsupervised doses are sold at exorbitant rates, demonstrates that excessive ...

Novo Nordisk's VP Dorethe Nielsen introduces the 'Suppliers for Zero' plan to help the firm meet its climate and nature goals ...

Novo Nordisk launches its Suppliers for Zero initiative to address the environmental impact of its supply chain, explains ...

This is read by an automated voice. Please report any issues or inconsistencies here. Gov. Gavin Newsom said $11 insulin pens will soon be available through the state’s pharmaceutical label.

The state of California is teaming up with the nonprofit generic drug maker Civica Rx and Biocon Biologics to offer an interchangeable biosimilar insulin glargine pen for $11 beginning January 1, 2026 ...

Gov. Gavin Newsom speaks during a news conference announcing $11 insulin and prescription drugs with the CalRx program inside a Cedars-Sinai pharmacy in Los Angeles on Thursday. The effort is part of ...

California will begin selling long-acting, low-cost insulin in January, becoming the first state to bypass major pharmaceutical companies, Gov. Gavin Newsom (D-CA) announced Thursday. The move marks a ...